Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review

Adverse drug events (ADEs) represent one of the most prevalent types of health-care-related harm, and there is substantial room for improvement in the way that they are currently predicted and detected. We conducted a scoping review to identify key use cases in which artificial intelligence (AI) cou...

Full description

Bibliographic Details

Published in:	The Lancet. Digital health Vol. 4; no. 2; pp. e137 - e148
Main Authors:	Syrowatka, Ania, Song, Wenyu, Amato, Mary G, Foer, Dinah, Edrees, Heba, Co, Zoe, Kuznetsova, Masha, Dulgarian, Sevan, Seger, Diane L, Simona, Aurélien, Bain, Paul A, Purcell Jackson, Gretchen, Rhee, Kyu, Bates, David W
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 01.02.2022 Elsevier
Subjects:	Artificial Intelligence Drug-Related Side Effects and Adverse Reactions - prevention & control Humans Informatics Internal Medicine Machine Learning
ISSN:	2589-7500, 2589-7500
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!